{"id":"NCT00465738","sponsor":"Merz Pharmaceuticals GmbH","briefTitle":"IncobotulinumtoxinA (Xeomin) for Upper Limb Spasticity","officialTitle":"Prospective, Randomized, Observer-blind, Parallel-group, Multi-center Trial to Assess Efficacy and Safety of Two Different Dilutions of incobotulinumtoxinA (Xeomin) in Patients With Upper Limb Spasticity","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-02","primaryCompletion":"2008-01","completion":"2008-05","firstPosted":"2007-04-25","resultsPosted":"2010-12-06","lastUpdate":"2010-12-31"},"enrollment":216,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Upper Limb Spasticity"],"interventions":[{"type":"DRUG","name":"incobotulinumtoxinA (Xeomin, also known as \"NT 201\" or \"Botulinum toxin type A (150 kD), free from complexing proteins\")","otherNames":["incobotulinumtoxinA","Xeomin","NT 201","Botulinum toxin type A (150 kD), free from complexing proteins"]}],"arms":[{"label":"incobotulinumtoxinA (Xeomin) High-volume Dilution 20 Units/mL","type":"EXPERIMENTAL"},{"label":"incobotulinumtoxinA (Xeomin) Low-volume Dilution 50 Units/mL","type":"ACTIVE_COMPARATOR"}],"summary":"This study will investigate the efficacy and safety of incobotulinumtoxinA (Xeomin) in the treatment of arm tightness (upper limb spasticity) using two different dilutions of incobotulinumtoxinA (Xeomin).","primaryOutcome":{"measure":"Responder in Disability Assessment Scale (DAS) at Week 4 - Per Protocol Set","timeFrame":"At week 4","effectByArm":[{"arm":"incobotulinumtoxinA (Xeomin) High-volume Dilution 20 Units/mL","deltaMin":51,"sd":null},{"arm":"incobotulinumtoxinA (Xeomin) Low-volume Dilution 50 Units/mL","deltaMin":44,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":7},"locations":{"siteCount":27,"countries":["Austria","France","Germany","Italy","Portugal","Spain","Switzerland","United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":96},"commonTop":["Epilepsy","Injection site haematoma","Nausea","Diarrhoea","Muscular weakness"]}}